Description
PRIMAQUINE 15 TABLET is a highly effective antimalarial tablet containing Primaquine Phosphate 15 mg. It is primarily used for the radical cure and relapse prevention of malaria caused by Plasmodium vivax and Plasmodium ovale. Unlike many antimalarials that target only blood-stage parasites, Primaquine also targets hypnozoites—the dormant liver forms that can cause relapse weeks or months after initial infection.
Mechanism of Action:
Primaquine belongs to the 8-aminoquinoline class of antimalarials and works by disrupting mitochondrial function and electron transport in the malaria parasite, especially within the liver stage. This unique action helps eliminate the parasite reservoir and prevents disease recurrence.
Radical cure of P. vivax and P. ovale malaria
Gametocidal activity in P. falciparum to prevent transmission
Part of combination regimens in malaria eradication programs
Effective in preventing relapse of malaria
Targets liver-stage parasites (hypnozoites)
Reduces disease transmission by clearing gametocytes
Suitable for use alongside other blood-stage antimalarials
Contraindicated in individuals with G6PD deficiency due to risk of hemolysis
Should not be used during pregnancy or lactation
Requires G6PD screening before initiation
Should be used under medical supervision
PRIMAQUINE 15 TABLET is manufactured under stringent pharmaceutical quality systems, adhering to WHO-GMP, ISO, and FDA-compliant protocols. It is tested for potency, safety, and stability in accordance with global pharmacopeial standards.
As a leading third-party manufacturer and global exporter, BLUEPILL EXPRESS supplies antimalarial medications like PRIMAQUINE 15 TABLET to hospitals, governments, NGOs, and pharmaceutical partners across Africa, Southeast Asia, Latin America, the Middle East, and beyond. Our scalable production and regulatory capabilities ensure uninterrupted international supply with complete documentation support.
Take orally with food to reduce gastrointestinal discomfort
Dosage and duration depend on weight, indication, and co-administered therapies
Always follow physician’s instructions and ensure G6PD testing prior to initiation
